Remus Pharmaceuticals submits Regulation 76 share capital audit disclosure for the quarter ended December 31, 2025, confirming regulatory compliance and transparency.
AI Assistant
Remus Pharmaceuticals Ltd
2026
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.